β-Hydroxybutyrate promotes chemoresistance and proliferation in breast cancer cells.

However, there is a clear trend of decreased cytotoxicity against 5-FU observed after 72 h (63.46 % in pre-treatment and 43.19 % in post-treatment) ( Fig. 3 a).

also in 19,460 other papers